|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
OLC1925765717 |
003 |
DE-627 |
005 |
20230518143828.0 |
007 |
tu |
008 |
130820s2013 xx ||||| 00| ||und c |
028 |
5 |
2 |
|a sw130816_1
|
035 |
|
|
|a (DE-627)OLC1925765717
|
035 |
|
|
|a (DE-599)GBVOLC1925765717
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
082 |
0 |
4 |
|a 610
|
084 |
|
|
|a PHARM
|2 fid
|
084 |
|
|
|a WA 15000
|q AVZ
|2 rvk
|
084 |
|
|
|a 44.40
|2 bkl
|
100 |
1 |
|
|a Musselman, Dominique
|e verfasserin
|4 aut
|
245 |
1 |
4 |
|a The Impact of Escitalopram on IL-2-Induced Neuroendocrine, Immune, and Behavioral Changes in Patients with Malignant Melanoma: Preliminary Findings
|
264 |
|
1 |
|c 2013
|
300 |
|
|
|a 8
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
700 |
1 |
|
|a Royster, Erica B
|4 oth
|
700 |
1 |
|
|a Wang, Ming
|4 oth
|
700 |
1 |
|
|a Long, Qi
|4 oth
|
700 |
1 |
|
|a Trimble, Lisa M
|4 oth
|
700 |
1 |
|
|a Mann, Tara K
|4 oth
|
700 |
1 |
|
|a Graciaa, Daniel S
|4 oth
|
700 |
1 |
|
|a McNutt, Marcia D
|4 oth
|
700 |
1 |
|
|a Auyeung, N S Freda
|4 oth
|
700 |
1 |
|
|a Oliver, Lindsay
|4 oth
|
700 |
1 |
|
|a Lawson, David H
|4 oth
|
700 |
1 |
|
|a Miller, Andrew H
|4 oth
|
773 |
0 |
8 |
|i Enthalten in
|t Neuropsychopharmacology
|d New York, NY : Springer Nature, 1987
|g 38(2013), 10 vom: 14. Sept., Seite 1921-1928
|w (DE-627)130433810
|w (DE-600)639471-1
|w (DE-576)022914307
|x 0893-133X
|7 nnns
|
773 |
1 |
8 |
|g volume:38
|g year:2013
|g number:10
|g day:14
|g month:09
|g pages:1921-1928
|g extent:8
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_OLC
|
912 |
|
|
|a FID-PHARM
|
912 |
|
|
|a SSG-OLC-PHA
|
912 |
|
|
|a SSG-OLC-PSY
|
912 |
|
|
|a SSG-OLC-DE-84
|
912 |
|
|
|a SSG-OPC-PHA
|
912 |
|
|
|a GBV_ILN_20
|
912 |
|
|
|a GBV_ILN_4012
|
912 |
|
|
|a GBV_ILN_4219
|
936 |
r |
v |
|a WA 15000
|
936 |
b |
k |
|a 44.40
|q AVZ
|
951 |
|
|
|a AR
|
952 |
|
|
|d 38
|j 2013
|e 10
|b 14
|c 9
|h 1921-1928
|g 8
|